Background:

Placental ribonuclease inhibitor (PRI) is a member of a family of proteinaceous cytoplasmic RNase inhibitors that occur in many tissues and bind to both intracellular and extracellular RNases (summarized by Lee et al., 1988 [PubMed 3219362]). In addition to control of intracellular RNases, the inhibitor may have a role in the regulation of angiogenin (MIM 105850). Ribonuclease inhibitor, of 50,000 Da, binds to ribonucleases and holds them in a latent form.

Applications:

ELISA, WB, IHC

Name of antibody:

RNH1

Immunogen:

Fusion protein of human RNH1

Full name:

ribonuclease/angiogenin inhibitor 1

Synonyms：

RAI; RNH

SwissProt:

P13489

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human breast cancer and human brain

IHC Recommend dilution:

25-100

WB Predicted band size:

50 kDa

WB Positive control:

Human fetal brain and normal liver tissue, human normal kidney tissue and hepg2 cells

WB Recommended dilution:

500-2000